News2022年6月4日Two Nucleic Acid Detection Kits for Sexually Transmitted Infections and Respiratory Tract Infections of Accunome Sciences Have Obtained CE Mark Certification
News2022年3月17日Fully Automated Sample-to-Answer Molecular Diagnostics Platform (DXcellence12) and Three Diagnostics Kits from Accunome Sciences Have Obtained CE Mark Certification
News2022年3月16日Accunome Science Has Raised A Total of More Than 100 million RMB of Financing to Accelerate Its Commercialization
News2022年3月15日Accunome Sciences was Ranked As one of “The Top 50 Most Promising Startups in 2021“ by Silicon Valley media “The Information”
